Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0756
D

Physician Inaction on Pharmacist's Medication Review

Exeter, Pennsylvania Survey Completed on 12-19-2024

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The attending physician failed to act upon pharmacist-identified irregularities in the medication regimen of a resident diagnosed with major depressive disorder and schizophrenia. The resident was prescribed Abilify, an antipsychotic medication, and the consultant pharmacist recommended a review for a gradual dose reduction. However, the attending physician did not document an appropriate response or provide justification for the continued use of Abilify in the resident's clinical record. Instead, the facility's consultant psychiatric CRNP responded to the pharmacy recommendation and signed off on it. An interview with the Director of Nursing confirmed that the attending physician did not provide the necessary documentation or justification for the medication regimen.

Plan Of Correction

Step 1 - Medical Director reviewed the pharmacy recommendations and noted the rational and justification for continued use of Abilify and reason for rejection of the GDR. Step 2 - Going forward when CRNP reviews and gives responses to pharmacy recommendations they will be reviewed and signed off by Medical Director. Step 3 - Education to CRNP's and medical director for need of review and signing off of pharmacy recommendations. Step 4 - Audits will be completed going forward of pharmacy recommendations to assure medical director signs off in agreement prior to adding to resident's chart. Monthly times 3. DON or designee. Step 5 - Results to QAPI monthly times 2.

An unhandled error has occurred. Reload 🗙